Today's pre-market stock movers: PTON, PEP, NVAX, GPS and more

Moomoo Breakfast US wrote a column · Jul 12, 2022 20:31

Gainers:

• $Canoo (GOEV.US)$ +71.3% (receives purchase order of 4500 Canoo Electric Delivery Vehicles from Walmart)

• $Aldeyra Therapeutics (ALDX.US)$ +14.1% (achieved primary endpoints in dry eye disease chamber crossover clinical trial)

• $Westport Fuel (WPRT.US)$ +10.9% (awarded 38 mln program)

• $Greenwich LifeSciences (GLSI.US)$ +5.9% (FDA has removed the clinical hold permitting the Flamingo-01 Phase III clinical trial to proceed; suspends share repurchase program)

• $BELLUS Health (BLU.US)$ +5.4% (reports End-of-Phase 2 Meeting with the FDA and its CALM Phase 3 Program for BLU-5937 in Refractory Chronic Cough)

• $Cohu Inc (COHU.US)$ +3.5% (Cohu (COHU) said Monday it expects Q2 revenue of $216 million to $218 million, higher than the guidance range mid-point of $213 million)

• $Leap Therapeutics (LPTX.US)$ +3.2% (Leap Therapeutics and BeiGene (BGNE) announce the initiation of Part C of the ongoing DisTinGuish study to evaluate DKN-01 Leap's anti-SSEDickkopf 1 (DKK1) antibody in combination with tislelizumab BeiGene's anti-PD-1 antibody)

• $Clarivate (CLVT.US)$ +3% (CEO to retire; names new CEO)

• $Peloton Interactive (PTON.US)$ +2.6% (exits owned-manufacturing and expands partnership with Rexon)

• $Dave & Buster's Entertainment (PLAY.US)$ +2.3% (names new execs following Main Event acquisition names new COO; entered into an amendment and restatement of the cooperation letter agreement with Hill Path Capital and James Chambers)

• $Aerojet Rocketdyne (AJRD.US)$ +2.3% (names new chairman)

• PEP+1.3% (PepsiCo Inc. reported a 5.2% increase in revenue in the latest quarter, driven by price increases and strong sales of its snacks and packaged foods)

Analyst comments:

• $Glaukos (GKOS.US)$ +2.1% (upgraded to Buy from Hold at Stifel)

Losers:

• $Fulcrum Therapeutics (FULC.US)$ -12.1% (CMO to step down)

• $VOXX International (VOXX.US)$ -11%,

• $RxSight (RXST.US)$ -6.7% (received notification from the FDA that additional information will be required for the approval of its lower- cost-to-manufacture Light Delivery Device)

• $Pliant Therapeutics (PLRX.US)$ -6.2% (stock offering)

• $Gap Inc (GPS.US)$ -6.1% (CEO will step down; names new CEO for Old Navy unit; reaffirms Q2 rev outlook but expects increased promotional activity)

• $Fluor (FLR.US)$ -4.1% (awarded a new contract by New Fortress Energy)

• $Novavax (NVAX.US)$ -2.2% (details modification to vaccine candidate for the SARS-CoV-2 virus contract)

• $Brookdale Senior Living (BKD.US)$ -2% (reports June operating metrics)

Analyst comments:

• $American Express (AXP.US)$ -2.6% (downgraded to Equal-Weight from Overweight at Morgan Stanley)

• $Capital One Financial (COF.US)$ -2.3% (downgraded to Equal-Weight from Overweight at Morgan Stanley; downgraded to Perform from Outperform at Oppenheimer)

• $C.H. Robinson Worldwide (CHRW.US)$ -1.5% (downgraded to Peer Perform from Outperform at Wolfe Research)

Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more

Translate

Report

330K Views

Comment

Moomoo Breakfast US

Moomoo News Official Account

Explore and integrate top feeds before the bell

66K

Followers

Following

67K

Visitors